I reckon we will peak now at 50p as too many sellers are ready when it rises these days. I can't believe I held for nearly 2 years now. Oh well hopefully one day it surges and I sell.
RE: Read the annual report - placing needed21 Mar 2023 11:50
They just tweeted this as well: NICE recommendations provide increased awareness of the utility and cost effectiveness of tests, and promote wider adoption of #innovation in the NHS
RE: Read the annual report - placing needed21 Mar 2023 11:48
It is funny he thinks it is ages away from any commercialisation when they have distribution agreements in lots of countries and are close to a mass rollout in the UK. They already made the product a long time back if you didn’t know.
RE: I'll say it once I'll say it again21 Mar 2023 09:13
Honestly it would be great if this surged to over £1 on March 30th 2023 after they announce NICE approval and nationwide rollout and no further funding required.
Today RNS seems like putting Genedrive back to the £1 share price days. Today’s news is huge when you check its contents. Seems it is already started the process of a mass rollout. See you in a week or so and this should be back to at least 70’s like it was in December 2021 or 60’s if there are too many profit takers. Yes I know it peaked at 82p but that was probably for a few seconds back then.
Jay I would love them to follow in Oxford Biodynamics footsteps and do it at a massive premium. That would be good. I think a £2M placing at 60p per share with directors only buying in.
Well 43p end is good. What is more Important is so many people are trading this stock everyday so if the buying pressure outweighs selling pressure this could rocket. Big chance of that rocketing next 2 weeks going by past history when news is due.